• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV prevalence and risk behaviours for HIV transmission in South Australian prisons.

作者信息

Gaughwin M D, Douglas R M, Liew C, Davies L, Mylvaganam A, Treffke H, Edwards J, Ali R

机构信息

Drug and Alcohol Services Council, S.A. Health Commission, Canberra.

出版信息

AIDS. 1991 Jul;5(7):845-51. doi: 10.1097/00002030-199107000-00008.

DOI:10.1097/00002030-199107000-00008
PMID:1892589
Abstract

During the latter half of 1989, HIV prevalence in South Australian prisoners was 1.4%. The prevalence of HIV infection across the prison system did not change significantly during 1989 but there was clustering of HIV-infected prisoners in some prisons. Almost half the prisoners from all of the South Australian prisons agreed to participate in our studies, from which we estimate that about 42% of prisoners engage in risk behaviours at least once while incarcerated. Prisoners estimated that 36% of all prisoners inject drugs intravenously at some stage during their stay and that 12% engage in anal intercourse at least once. Interviews with former prisoners who had a history of intravenous drug use revealed that about half had injected themselves while in prison, 60% shared needles and most did not clean shared needles adequately. Most of these prisoners injected themselves once a month or less frequently. The conditions for spread of HIV within the prison system exist but at the current prevalence of infection, transmission can be expected to be infrequent. The opportunity exists now to improve and expand preventive measures.

摘要

相似文献

1
HIV prevalence and risk behaviours for HIV transmission in South Australian prisons.
AIDS. 1991 Jul;5(7):845-51. doi: 10.1097/00002030-199107000-00008.
2
Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.印度尼西亚感染艾滋病毒的男性囚犯在监狱内注射毒品:一种选择极为受限的行为。
Drug Alcohol Depend. 2015 Apr 1;149:71-9. doi: 10.1016/j.drugalcdep.2015.01.018. Epub 2015 Jan 25.
3
People who inject drugs in prison: HIV prevalence, transmission and prevention.监狱中注射毒品者:艾滋病毒流行率、传播与预防
Int J Drug Policy. 2015 Feb;26 Suppl 1:S12-5. doi: 10.1016/j.drugpo.2014.10.012. Epub 2014 Dec 1.
4
Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie.在苏格兰最大的监狱巴林尼监狱进行的具有风险因素诱导的匿名艾滋病毒监测。
AIDS. 1995 Jul;9(7):801-8. doi: 10.1097/00002030-199507000-00019.
5
HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009.伊朗囚犯中的 HIV 流行率和相关风险行为:2009 年全国生物行为调查结果。
Sex Transm Infect. 2013 Nov;89 Suppl 3(Suppl 3):iii33-6. doi: 10.1136/sextrans-2013-051295. Epub 2013 Aug 28.
6
Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison.监狱内减少伤害措施与注射行为对比强制药物检测:横断面匿名问卷调查结果。欧盟监狱艾滋病毒感染与肝炎问题网络
BMJ. 1997 Jul 5;315(7099):21-4. doi: 10.1136/bmj.315.7099.21.
7
HIV in UK prisons: a review of seroprevalence, transmission and patterns of risk.英国监狱中的艾滋病病毒:血清流行率、传播及风险模式综述
Int J STD AIDS. 1995 Nov-Dec;6(6):387-91. doi: 10.1177/095646249500600602.
8
HIV testing, HIV infection and associated risk factors among inmates in south-eastern French prisons.法国东南部监狱囚犯中的艾滋病毒检测、艾滋病毒感染及相关风险因素
AIDS. 1994 Sep;8(9):1341-4. doi: 10.1097/00002030-199409000-00020.
9
HIV transmission in a prison system in an Australian State.澳大利亚某州监狱系统中的艾滋病毒传播情况。
Med J Aust. 1999 Jul 5;171(1):14-7. doi: 10.5694/j.1326-5377.1999.tb123490.x.
10
Risk behaviours for HIV infection among drug users in prison.监狱中吸毒者感染艾滋病毒的风险行为。
BMJ. 1990 May 26;300(6736):1383-4. doi: 10.1136/bmj.300.6736.1383.

引用本文的文献

1
Examining risk factors for HIV infection amongst male inmates in Peruvian prisons: a cross-sectional study using national prisoner census data.秘鲁监狱男性囚犯中艾滋病毒感染风险因素的调查:一项利用全国囚犯普查数据的横断面研究。
Rev Esp Sanid Penit. 2024 Sep-Dec;26(3):82-91. doi: 10.18176/resp.00093.
2
Prevalence of HIV/AIDS among Iranian Prisoners: A Review Article.伊朗囚犯中艾滋病毒/艾滋病的流行情况:一篇综述文章。
Addict Health. 2016 Jul;8(3):195-206.
3
The political and scientific challenges in evaluating compulsory drug treatment centers in Southeast Asia.
评估东南亚强制戒毒中心所面临的政治和科学挑战。
Harm Reduct J. 2017 Jan 11;14(1):2. doi: 10.1186/s12954-016-0130-1.
4
Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users.监禁是静脉注射吸毒者中血源性感染的主要风险因素:静脉注射吸毒者中的监禁与血源性感染。
Hepat Mon. 2011 Jan;11(1):19-22.
5
Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran.伊朗一所监狱中服刑人员的药物使用模式和与艾滋病毒相关的危险行为。
J Urban Health. 2010 Jul;87(4):603-16. doi: 10.1007/s11524-010-9450-8.
6
Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran.伊朗哈马丹地区吸毒囚犯中丙型肝炎病毒感染率及其相关危险因素
World J Gastroenterol. 2005 Jul 14;11(26):4085-9. doi: 10.3748/wjg.v11.i26.4085.
7
Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.爱尔兰囚犯中乙肝、丙肝和艾滋病毒抗体的流行情况及危险因素:一项全国横断面调查结果
BMJ. 2000 Jul 8;321(7253):78-82. doi: 10.1136/bmj.321.7253.78.
8
New York inmates' HIV risk behaviors: the implications for prevention policy and programs.纽约囚犯的艾滋病毒风险行为:对预防政策和项目的影响。
Am J Public Health. 1996 Sep;86(9):1211-5. doi: 10.2105/ajph.86.9.1211.
9
Sentinel hospital surveillance of HIV infection in Quebec. Quebec Sentinel Hospital HIV-Seroprevalence Study Group.魁北克艾滋病病毒感染的哨点医院监测。魁北克哨点医院艾滋病病毒血清流行率研究小组。
CMAJ. 1994 Oct 1;151(7):975-81.
10
Spread of bloodborne viruses among Australian prison entrants.血源性病原体在澳大利亚新入狱囚犯中的传播情况。
BMJ. 1995 Feb 4;310(6975):285-8. doi: 10.1136/bmj.310.6975.285.